Position in VTRS
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$7,494,374
-$47,232 QoQ
Shares Held
471,938
-15.5% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#145
of 1,020 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 11%
Shared 5%
None 85%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $93,224,797 across 28 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
487,990 | $35,066,961 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
54,680 | $9,215,766 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
342,271 | $8,423,288 | |
| 4 | VTRS |
Viatris Inc
This page
|
471,938 | $7,494,374 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
13,429 | $7,276,234 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
209,792 | $3,039,885 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
150,698 | $2,608,582 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
71,870 | $2,601,694 |
All Filings in VTRS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,494,374 | 471,938 | Shares | Other | 2026-08-27 | |
| 2026-03-31 | $7,541,606 | 558,224 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $5,680,748 | 456,285 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $4,614,547 | 466,116 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,802,275 | 425,787 | Shares | Sole | 2025-09-26 | |
| 2025-03-31 | $4,079,972 | 468,424 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,301,087 | 666,754 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $7,924,787 | 682,583 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $6,221,558 | 585,283 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $8,790,704 | 736,240 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,167,963 | 661,862 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $6,789,210 | 688,561 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $4,774,890 | 478,446 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $2,537,081 | 263,730 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $994,909 | 89,390 | Shares | Other | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||